Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 6Unknown 3Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 2Inflammation 1Fatigue 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Chromatin Immunoprecipitation Sequencing × Clear all
NCT05888636 2024-03-22

TEDROMM

Regina Elena Cancer Institute

Unknown
200 enrolled
Plasma cell

Multiple Myeloma

NCT05858203 2023-05-15

AATF/Che-1

Regina Elena Cancer Institute

Unknown
150 enrolled
Plasma cell

Multiple Myeloma

NCT03259438 2017-08-23

The Vitality Project for Fatigued Female Cancer Survivors

The Miriam Hospital

Phase NA Unknown
75 enrolled

Fatigue, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡